{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:31:28Z","timestamp":1779114688658,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.11.028","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T15:30:53Z","timestamp":1164727853000},"page":"1780-1788","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax"],"prefix":"10.1016","volume":"25","author":[{"given":"V.A.","family":"Semenova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"T.H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Steward-Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.D.","family":"Soroka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.11.028_bib1","unstructured":"Downloaded from http:\/\/www.emergentbiosolutions.com\/pdf\/emergent_biothrax_us.pdf. [accessed on October 20, 2006]."},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.028_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00152686","article-title":"Recent advances in the development of an improved, human anthrax vaccine","volume":"4","author":"Ivins","year":"1988","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.028_bib3","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"1","author":"Little","year":"1999","journal-title":"Microbes Infect"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2006.11.028_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.028_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human Immunoglobulin G antibodies to anthrax protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.028_bib8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2672.1999.00899.x","article-title":"Human immune responses to the UK human anthrax vaccine","volume":"87","author":"Baillie","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.028_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.028_bib11","series-title":"The human IgG subclasses: molecular analysis of structure, function and regulation","first-page":"93","article-title":"Structure-function relationships of IgG subclasses","author":"Jefferis","year":"1990"},{"key":"10.1016\/j.vaccine.2006.11.028_bib12","article-title":"The human IgG subclasses","author":"Hamilton","year":"1998","journal-title":"Calbiochem"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.028_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.028_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CDLI.11.5.919-923.2004","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum","volume":"11","author":"Semenova","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.11.028_bib15","first-page":"153","article-title":"Purification and characterization of adenylyl cyclase from Bacillus anthracis","volume":"19","author":"Leppla","year":"1991"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.028_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","article-title":"Optimized production and purification of Bacillus anthracis lethal factor","volume":"18","author":"Park","year":"2000","journal-title":"Protein Exp Purif"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.028_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/hyb.1984.3.263","article-title":"Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes","volume":"3","author":"Reimer","year":"1984","journal-title":"Hybridoma"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2006.11.028_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-2478(85)90082-3","article-title":"Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS\/WHO collaborative study","volume":"10","author":"Jefferis","year":"1985","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2006.11.028_bib19","unstructured":"Downloaded from http:\/\/www.cdc.gov\/ncidod\/dbmd\/bimb\/elisa.htm. [accessed on September 25, 2004]."},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.028_bib20","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/JCM.32.10.2441-2447.1994","article-title":"Determination of parallelism and nonparallelism in bioassay dilution curves","volume":"2","author":"Plikaytis","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-7439(93)80008-6","article-title":"Calibration and assay development using the four-parameter logistic model","volume":"20","author":"O\u2019Connell","year":"1993","journal-title":"Chemometr Intell Lab Syst"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the UK anthrax vaccine","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immun Med Microbiol"},{"key":"10.1016\/j.vaccine.2006.11.028_bib23","unstructured":"Bradwell AR. IgG and IgA subclasses in disease. The Binding Site, 1995. p. 29."},{"key":"10.1016\/j.vaccine.2006.11.028_bib24","series-title":"The human IgG subclasses: molecular analysis of structure, function and regulation","first-page":"161","article-title":"Selective IgG subclass expression: biologic, clinical and functional aspects","author":"Scott","year":"1990"},{"key":"10.1016\/j.vaccine.2006.11.028_bib25","first-page":"122","article-title":"IgG subclasses changes in bacterial infections","volume":"19","author":"Hammarstrom","year":"1986","journal-title":"Monogr Allerg"},{"key":"10.1016\/j.vaccine.2006.11.028_bib26","first-page":"27","article-title":"IgG susclasses to subviral components","volume":"23","author":"Linde","year":"1988","journal-title":"Monogr Allerg"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.028_bib27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1203\/00006450-199506000-00023","article-title":"Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infection","volume":"37","author":"Sanders","year":"1995","journal-title":"Pediatr Res"},{"issue":"13","key":"10.1016\/j.vaccine.2006.11.028_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0264-410X(99)00394-1","article-title":"The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection","volume":"18","author":"Gregorek","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.028_bib29","first-page":"693","article-title":"Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals","volume":"9","author":"Isa","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.028_bib30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1128\/JCM.27.7.1567-1571.1989","article-title":"Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine","volume":"27","author":"Zackrisson","year":"1989","journal-title":"Clin Microb"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.028_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jmv.1890300203","article-title":"Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A","volume":"30","author":"Hocart","year":"1990","journal-title":"Med Virol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2006.11.028_bib32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.028_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2006.11.028_bib34","series-title":"The human IgG subclasses: molecular analysis of structure, function and regulation","first-page":"185","article-title":"Affinity of IgG subclass antibodies","author":"Devey","year":"1990"},{"key":"10.1016\/j.vaccine.2006.11.028_bib35","unstructured":"Taylor T, Quinn C, Schmidt D, Freeman A, Li H, Semenova V, Hoekstra R, Plikaytis B. Novel mathematical approach to TNA endpoints. Abstracts of the 5th International Meeting on Anthrax, Nice, France, March 31\u2013April 4, 2003."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T03:55:08Z","timestamp":1587268508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0601231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X0601231X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}